MSAs were found in 42.9% of the total cohort and in those where further clinical details were available were mostly associated with cutaneous features, apart from anti-Jo-1 and anti-SRP that were associated with arthritis and cardiac involvement respectively. This evidence concerns the gene UCN2 and Arthritis.